HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Eijun Itakura Selected Research
Eijun Itakura Research Topics
Disease
8
Melanoma (Melanoma, Malignant)
12/2020 - 10/2004
7
Neoplasms (Cancer)
06/2019 - 02/2002
3
Neoplasm Metastasis (Metastasis)
01/2015 - 06/2011
2
Lymphatic Metastasis
01/2008 - 09/2006
1
Drug-Related Side Effects and Adverse Reactions
08/2020
1
Lymphangioma (Cavernous Lymphangioma)
03/2009
1
Cystic Lymphangioma (Hygroma)
03/2009
1
Nevus (Nevi)
03/2008
1
Hemangiosarcoma (Angiosarcoma)
01/2008
1
Lymphedema (Milroy Disease)
01/2008
1
Rhabdoid Tumor (Rhabdoid Tumors)
02/2002
Drug/Important Bio-Agent (IBA)
3
Ipilimumab
IBA
12/2020 - 11/2019
3
Messenger RNA (mRNA)
IBA
11/2011 - 03/2008
2
Nivolumab
IBA
12/2020 - 11/2019
2
Immune Checkpoint Inhibitors
IBA
08/2020 - 06/2019
2
Cytokines
IBA
01/2015 - 06/2011
2
Formaldehyde (Formol)
FDA Link
11/2011 - 03/2008
2
Paraffin
IBA
11/2011 - 03/2008
2
RNA-Directed DNA Polymerase (Reverse Transcriptase)
IBA
11/2011 - 06/2011
2
Vascular Endothelial Growth Factor C
IBA
03/2009 - 01/2008
1
CTLA-4 Antigen
IBA
08/2020
1
Monoclonal Antibodies
IBA
08/2020
1
Proteins (Proteins, Gene)
FDA Link
11/2011
1
Hematoxylin (Haematoxylon)
IBA
11/2011
1
Eosine Yellowish-(YS) (Eosin)
IBA
11/2011
1
RNA (Ribonucleic Acid)
IBA
11/2011
1
Interleukin-10 (Interleukin 10)
IBA
06/2011
1
Vascular Endothelial Growth Factor Receptor-3 (Flt 4)
IBA
03/2009
1
Intercellular Signaling Peptides and Proteins (Growth Factors)
IBA
03/2009
1
dopachrome isomerase
IBA
03/2008
1
Epitopes
IBA
03/2008
1
MART-1 Antigen
IBA
03/2008
1
Vascular Endothelial Growth Factors
IBA
01/2008
1
Vascular Endothelial Growth Factor Receptor-1 (fms-Like Tyrosine Kinase)
IBA
01/2008
1
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2008
1
Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
IBA
09/2006
1
Keratins (Keratin)
IBA
02/2002
1
Keratin-8 (Keratin 8)
IBA
02/2002
1
Indicators and Reagents (Reagents)
IBA
02/2002
1
Vimentin
IBA
02/2002
Therapy/Procedure
2
Therapeutics
12/2020 - 09/2006
1
Lymph Node Excision (Lymph Node Dissection)
10/2004